Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-005756
Filing Date
2012-05-10
Accepted
2012-05-10 16:18:04
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2209484z10-q.htm 10-Q 435653
2 EX-31.1 a2209484zex-31_1.htm EX-31.1 8415
3 EX-31.2 a2209484zex-31_2.htm EX-31.2 8410
4 EX-32.1 a2209484zex-32_1.htm EX-32.1 9049
  Complete submission text file 0001047469-12-005756.txt   2260790

Data Files

Seq Description Document Type Size
5 EX-101.INS astx-20120331.xml EX-101.INS 203984
6 EX-101.SCH astx-20120331.xsd EX-101.SCH 21229
7 EX-101.CAL astx-20120331_cal.xml EX-101.CAL 41984
8 EX-101.DEF astx-20120331_def.xml EX-101.DEF 90650
9 EX-101.LAB astx-20120331_lab.xml EX-101.LAB 309417
10 EX-101.PRE astx-20120331_pre.xml EX-101.PRE 144931
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

EIN.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 12830537
SIC: 2834 Pharmaceutical Preparations